Analysts’ Top Healthcare Picks: Danaher (DHR), Edwards Lifesciences (EW)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Danaher (DHR – Research Report) and Edwards Lifesciences (EW – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Danaher (DHR)
In a report released yesterday, Casey Woodring from J.P. Morgan maintained a Buy rating on Danaher, with a price target of $275.00. The company’s shares closed last Thursday at $219.62.
According to TipRanks.com, Woodring is a 1-star analyst with an average return of
Danaher has an analyst consensus of Strong Buy, with a price target consensus of $266.18, which is a 19.2% upside from current levels. In a report issued on January 28, TipRanks – DeepSeek also upgraded the stock to Buy with a $263.00 price target.
See the top stocks recommended by analysts >>
Edwards Lifesciences (EW)
In a report released today, Adam Maeder from Piper Sandler maintained a Buy rating on Edwards Lifesciences, with a price target of $98.00. The company’s shares closed last Thursday at $81.49.
According to TipRanks.com, Maeder is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Edwards Lifesciences with a $97.90 average price target, a 18.7% upside from current levels. In a report issued on January 16, Bank of America Securities also maintained a Buy rating on the stock with a $103.00 price target.
